Antoine Chatrenet

632 total citations
34 papers, 402 citations indexed

About

Antoine Chatrenet is a scholar working on Nephrology, Pediatrics, Perinatology and Child Health and Obstetrics and Gynecology. According to data from OpenAlex, Antoine Chatrenet has authored 34 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Nephrology, 9 papers in Pediatrics, Perinatology and Child Health and 9 papers in Obstetrics and Gynecology. Recurrent topics in Antoine Chatrenet's work include Dialysis and Renal Disease Management (14 papers), Pregnancy and preeclampsia studies (8 papers) and Nutrition and Health in Aging (6 papers). Antoine Chatrenet is often cited by papers focused on Dialysis and Renal Disease Management (14 papers), Pregnancy and preeclampsia studies (8 papers) and Nutrition and Health in Aging (6 papers). Antoine Chatrenet collaborates with scholars based in France, Italy and Taiwan. Antoine Chatrenet's co-authors include Giorgina Barbara Piccoli, Antioco Fois, Massimo Torreggiani, Gianfranca Cabiddu, Adamasco Cupisti, Rossella Attini, Bianca Covella, Giuseppe Regolisti, Roberto Russo and Carlo Ferraresi and has published in prestigious journals such as Kidney International, Medicine & Science in Sports & Exercise and Nutrients.

In The Last Decade

Antoine Chatrenet

33 papers receiving 396 citations

Peers

Countries citing papers authored by Antoine Chatrenet

Since Specialization

Citations

This map shows the geographic impact of Antoine Chatrenet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antoine Chatrenet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antoine Chatrenet more than expected).

Fields of papers citing papers by Antoine Chatrenet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antoine Chatrenet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antoine Chatrenet. The network helps show where Antoine Chatrenet may publish in the future.

Co-authorship network of co-authors of Antoine Chatrenet

This figure shows the co-authorship network connecting the top 25 collaborators of Antoine Chatrenet. A scholar is included among the top collaborators of Antoine Chatrenet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antoine Chatrenet. Antoine Chatrenet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Recurrence of preeclampsia is common, even during rigorously controlled multidisciplinary follow-up: a pilot experience 2025 ·Clinical Kidney Journal ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Antioco Fois, (unknown), Antoine Chatrenet, Mario Salomone, Massimo Torreggiani, (unknown)	0
2	Quality matters: chronic kidney disease progression is associated with reduced muscle strength independently of changes in skeletal muscle mass: an observational study 2025 ·Clinical Kidney Journal ·Antoine Chatrenet, (unknown), Massimo Torreggiani, (unknown), (unknown), (unknown), (unknown)	2
3	Any reduction in maternal kidney mass makes a difference during pregnancy in gestational and fetal outcome 2024 ·Kidney International ·Giorgina Barbara Piccoli, Rossella Attini, Massimo Torreggiani, Antoine Chatrenet, (unknown), Bianca Masturzo, (unknown), (unknown), (unknown), Luigi Biancone, Antonello Pani, Gianfranca Cabiddu	5
4	Adipokines and Myokines as Markers of Malnutrition and Sarcopenia in Patients Receiving Kidney Replacement Therapy: An Observational, Cross-Sectional Study 2024 ·Nutrients ·(unknown), Antoine Chatrenet, (unknown), Jakub Ruszkowski, Massimo Torreggiani, Monika Lichodziejewska–Niemierko, Alicja Dębska‐Ślizień, Giorgina Barbara Piccoli, Sylwia Małgorzewicz	7
5	Analysis of the rate of force development reveals high neuromuscular fatigability in elderly patients with chronic kidney disease 2023 ·Journal of Cachexia Sarcopenia and Muscle ·Antoine Chatrenet, Giorgina Barbara Piccoli, (unknown), Massimo Torreggiani, J. Barbieux, (unknown), Baptiste Morel, Sylvain Durand, Bruno Beaune	9
6	Plant-Based Diets Improve Maternal–Fetal Outcomes in CKD Pregnancies 2022 ·Nutrients ·Rossella Attini, Filomena Leone, Antoine Chatrenet, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Bianca Masturzo, Massimo Torreggiani, Alberto Revelli, Gianfranca Cabiddu, Giorgina Barbara Piccoli	8
7	Incremental and Personalized Hemodialysis Start: A New Standard of Care 2022 ·Kidney International Reports ·Massimo Torreggiani, Antioco Fois, Antoine Chatrenet, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Guillaume Séret, (unknown), Pierre Ronco, Frédéric Lavainne, Giorgina Barbara Piccoli	21
8	Quality of Life in CKD Patients on Low-Protein Diets in a Multiple-Choice Diet System. Comparison between a French and an Italian Experience 2021 ·Nutrients ·Antioco Fois, Massimo Torreggiani, (unknown), Antoine Chatrenet, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Giorgina Barbara Piccoli	18
9	Supplemented Low-Protein Diet May Delay the Need for Preemptive Kidney Transplantation: A Nationwide Population-Based Cohort Study 2021 ·Nutrients ·Chieh‐Li Yen, Pei‐Chun Fan, George Kuo, Chao‐Yu Chen, (unknown), Hsiang‐Hao Hsu, (unknown), Antoine Chatrenet, Giorgina Barbara Piccoli, Chih‐Hsiang Chang	2
10	Hypnosis in Treatment of Stomatodynia: Preliminary Retrospective Study of 12 Cases 2021 ·International Journal of Clinical and Experimental Hypnosis ·(unknown), (unknown), Giorgina Barbara Piccoli, Antoine Chatrenet, H. Maillard	1
11	Hypernatraemia and low eGFR at hospitalization in COVID-19 patients: a deadly combination 2021 ·Clinical Kidney Journal ·(unknown), Chiara Nardi, Vincenzo Calabrese, Roberta Messina, (unknown), Emmanuele Venanzi Rullo, Manuela Ceccarelli, Antoine Chatrenet, Patrick Saulnier, Massimo Torreggiani, Giuseppe Nunnari, Giorgina Barbara Piccoli, Domenico Santoro	5
12	Toward an individualized determination of dialysis adequacy: a narrative review with special emphasis on incremental hemodialysis 2021 ·Expert Review of Molecular Diagnostics ·Massimo Torreggiani, Antioco Fois, (unknown), (unknown), Antoine Chatrenet, Ciro Esposito, Hafedh Fessi, Giorgina Barbara Piccoli	7
13	Spontaneously Low Protein Intake in Elderly CKD Patients: Myth or Reality? Analysis of Baseline Protein Intake in a Large Cohort of Patients with Advanced CKD 2021 ·Nutrients ·Massimo Torreggiani, Antioco Fois, (unknown), Antoine Chatrenet, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Giorgina Barbara Piccoli	14
14	Pedobarographic Statistical Parametric Mapping may identify specific plantar pressure patterns in patients with diabetes mellitus among different degrees of peripheral neuropathy: A pilot study 2021 ·Diabetic Medicine ·Antoine Chatrenet, Bruno Beaune, (unknown), Massimo Torreggiani, Giorgina Barbara Piccoli, Baptiste Morel	4
15	Unmet needs for CKD care: from the general population to the CKD clinics—how many patients are we missing? 2021 ·Clinical Kidney Journal ·Massimo Torreggiani, Antoine Chatrenet, Antioco Fois, (unknown), Romain Crochette, (unknown), (unknown), Guillaume Séret, (unknown), (unknown), (unknown), Hafedh Fessi, Giorgina Barbara Piccoli	11
16	Ready to Change: Attitudes of an Elderly CKD Stage 3–5 Population towards Testing Protein-Free Food 2020 ·Nutrients ·(unknown), (unknown), Antioco Fois, Antoine Chatrenet, (unknown), (unknown), (unknown), (unknown), Domenico Santoro, Massimo Torreggiani, Giorgina Barbara Piccoli	5
17	New Intravenous Calcimimetic Agents: New Options, New Problems. An Example on How Clinical, Economical and Ethical Considerations Affect Choice of Treatment 2020 ·International Journal of Environmental Research and Public Health ·Giorgina Barbara Piccoli, (unknown), Antoine Chatrenet, (unknown), (unknown), (unknown), Antioco Fois, (unknown), Patrick Saulnier, Nicola Panocchia	2
18	PhysIOpathology of NEuromuscular function rElated to fatigue in chronic Renal disease in the elderly (PIONEER): study protocol 2020 ·BMC Nephrology ·Antoine Chatrenet, Bruno Beaune, Antioco Fois, (unknown), (unknown), Massimo Torreggiani, Damien B.B.P. Paris, Sylvain Durand, Giorgina Barbara Piccoli	4
19	Positron Emission Tomography Can Support the Diagnosis of Dialysis-Related Amyloidosis 2019 ·Journal of Clinical Medicine ·(unknown), (unknown), (unknown), Antoine Chatrenet, Daniele Penna, Ettore Pelosi, (unknown), (unknown), (unknown), (unknown), Patrick Saulnier, Vincenzo Arena, (unknown), Giorgina Barbara Piccoli	3
20	Moderate Protein Restriction in Advanced CKD: A Feasible Option in An Elderly, High-Comorbidity Population. A Stepwise Multiple-Choice System Approach 2018 ·Nutrients ·Antioco Fois, Antoine Chatrenet, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Irene Capizzi, Marilisa Biolcati, Elisabetta Versino, Giorgina Barbara Piccoli	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact